| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mesothelioma | 15 | 2023 | 135 | 2.470 |
Why?
|
| Ubiquitin Thiolesterase | 8 | 2023 | 48 | 1.580 |
Why?
|
| Tumor Suppressor Proteins | 9 | 2023 | 184 | 1.340 |
Why?
|
| Brain Neoplasms | 10 | 2017 | 105 | 1.180 |
Why?
|
| Lung Neoplasms | 8 | 2022 | 336 | 1.140 |
Why?
|
| HMGB1 Protein | 5 | 2023 | 29 | 0.910 |
Why?
|
| Pleural Neoplasms | 3 | 2016 | 51 | 0.830 |
Why?
|
| Glioblastoma | 8 | 2017 | 49 | 0.810 |
Why?
|
| Asbestos | 5 | 2023 | 47 | 0.790 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2016 | 82 | 0.630 |
Why?
|
| Glioma | 5 | 2015 | 76 | 0.630 |
Why?
|
| Cell Nucleus | 4 | 2021 | 351 | 0.600 |
Why?
|
| Mutation | 7 | 2023 | 1023 | 0.470 |
Why?
|
| Phosphoproteins | 2 | 2010 | 154 | 0.420 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2020 | 166 | 0.410 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2014 | 178 | 0.390 |
Why?
|
| Mice | 26 | 2023 | 5668 | 0.370 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2010 | 57 | 0.370 |
Why?
|
| Germ-Line Mutation | 4 | 2022 | 51 | 0.330 |
Why?
|
| Melanoma | 2 | 2022 | 91 | 0.320 |
Why?
|
| Molecular Biology | 1 | 2008 | 44 | 0.310 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2022 | 528 | 0.310 |
Why?
|
| Animals | 29 | 2023 | 14307 | 0.290 |
Why?
|
| Picolinic Acids | 6 | 2006 | 12 | 0.260 |
Why?
|
| Signal Transduction | 5 | 2017 | 1802 | 0.260 |
Why?
|
| Mitochondria | 3 | 2017 | 454 | 0.250 |
Why?
|
| Humans | 35 | 2023 | 34853 | 0.250 |
Why?
|
| Antineoplastic Agents | 6 | 2017 | 756 | 0.240 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2023 | 81 | 0.240 |
Why?
|
| Histone Deacetylase 1 | 1 | 2021 | 14 | 0.210 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2017 | 781 | 0.210 |
Why?
|
| Epithelial Cells | 3 | 2020 | 366 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2015 | 52 | 0.210 |
Why?
|
| Autophagy | 2 | 2020 | 111 | 0.210 |
Why?
|
| Asbestosis | 1 | 2020 | 6 | 0.200 |
Why?
|
| Xenograft Model Antitumor Assays | 7 | 2017 | 242 | 0.200 |
Why?
|
| Heterozygote | 4 | 2023 | 91 | 0.190 |
Why?
|
| RecQ Helicases | 1 | 2020 | 35 | 0.190 |
Why?
|
| Skin Neoplasms | 1 | 2022 | 151 | 0.190 |
Why?
|
| Tumor Cells, Cultured | 8 | 2017 | 480 | 0.190 |
Why?
|
| Cell Line, Tumor | 11 | 2017 | 2128 | 0.180 |
Why?
|
| Cell Hypoxia | 5 | 2011 | 55 | 0.180 |
Why?
|
| Immunohistochemistry | 3 | 2016 | 859 | 0.180 |
Why?
|
| Apoptosis | 6 | 2017 | 1317 | 0.170 |
Why?
|
| Biopsy | 2 | 2016 | 151 | 0.170 |
Why?
|
| Cell Proliferation | 6 | 2017 | 1149 | 0.170 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2010 | 90 | 0.170 |
Why?
|
| Macrophages | 5 | 2006 | 431 | 0.170 |
Why?
|
| Cell Survival | 7 | 2017 | 818 | 0.160 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 555 | 0.160 |
Why?
|
| Mice, Knockout | 4 | 2020 | 897 | 0.160 |
Why?
|
| Endothelial Cells | 3 | 2011 | 296 | 0.160 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2017 | 9 | 0.150 |
Why?
|
| Pyruvates | 1 | 2017 | 5 | 0.150 |
Why?
|
| Stem Cell Factor | 2 | 2008 | 4 | 0.150 |
Why?
|
| Guanidines | 1 | 2017 | 17 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2016 | 9 | 0.150 |
Why?
|
| Cytoplasm | 1 | 2017 | 135 | 0.150 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2016 | 17 | 0.150 |
Why?
|
| DNA, Neoplasm | 2 | 2015 | 86 | 0.150 |
Why?
|
| Endoplasmic Reticulum | 1 | 2017 | 101 | 0.150 |
Why?
|
| Chromosome Deletion | 1 | 2016 | 52 | 0.150 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 79 | 0.140 |
Why?
|
| Magnesium Compounds | 1 | 2016 | 2 | 0.140 |
Why?
|
| Silicon Compounds | 1 | 2016 | 5 | 0.140 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 211 | 0.140 |
Why?
|
| Uveal Neoplasms | 1 | 2015 | 8 | 0.140 |
Why?
|
| Drug Design | 1 | 2017 | 154 | 0.140 |
Why?
|
| Macrophage Activation | 4 | 2004 | 52 | 0.140 |
Why?
|
| Protein Binding | 5 | 2021 | 913 | 0.130 |
Why?
|
| Mice, SCID | 5 | 2017 | 143 | 0.130 |
Why?
|
| Glutamine | 1 | 2015 | 31 | 0.130 |
Why?
|
| Interferon-gamma | 4 | 2004 | 235 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 338 | 0.130 |
Why?
|
| Prognosis | 4 | 2021 | 707 | 0.120 |
Why?
|
| Calcium | 1 | 2017 | 445 | 0.120 |
Why?
|
| Drug Approval | 1 | 2014 | 6 | 0.120 |
Why?
|
| United States Food and Drug Administration | 1 | 2014 | 22 | 0.120 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 96 | 0.120 |
Why?
|
| Down-Regulation | 5 | 2014 | 420 | 0.120 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2014 | 107 | 0.120 |
Why?
|
| Staurosporine | 1 | 2013 | 35 | 0.120 |
Why?
|
| Nanocapsules | 1 | 2013 | 16 | 0.120 |
Why?
|
| Neoplasms, Experimental | 1 | 2013 | 36 | 0.120 |
Why?
|
| Environmental Exposure | 1 | 2016 | 207 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 5 | 2010 | 1530 | 0.120 |
Why?
|
| Inflammation | 3 | 2023 | 577 | 0.120 |
Why?
|
| Piperidines | 2 | 2004 | 76 | 0.120 |
Why?
|
| Flavonoids | 2 | 2004 | 78 | 0.110 |
Why?
|
| Liposomes | 1 | 2013 | 107 | 0.110 |
Why?
|
| Protein Kinase C | 1 | 2013 | 110 | 0.110 |
Why?
|
| Carrier Proteins | 1 | 2015 | 287 | 0.110 |
Why?
|
| Neuroblastoma | 2 | 2004 | 128 | 0.110 |
Why?
|
| Mice, Nude | 4 | 2017 | 323 | 0.110 |
Why?
|
| Incidence | 3 | 2021 | 882 | 0.110 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2010 | 146 | 0.100 |
Why?
|
| Cell Transdifferentiation | 1 | 2011 | 8 | 0.100 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2011 | 48 | 0.100 |
Why?
|
| Neoplastic Stem Cells | 2 | 2014 | 74 | 0.100 |
Why?
|
| Jurkat Cells | 1 | 2010 | 72 | 0.090 |
Why?
|
| Cells, Cultured | 4 | 2020 | 1442 | 0.090 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2010 | 54 | 0.090 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 239 | 0.090 |
Why?
|
| Interleukin-2 | 1 | 2010 | 87 | 0.090 |
Why?
|
| Female | 10 | 2021 | 19873 | 0.090 |
Why?
|
| Aged | 5 | 2020 | 6448 | 0.090 |
Why?
|
| Ubiquitin | 2 | 2021 | 76 | 0.090 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2008 | 27 | 0.080 |
Why?
|
| Bone Marrow Transplantation | 1 | 2008 | 15 | 0.080 |
Why?
|
| Cell Line | 5 | 2015 | 1289 | 0.080 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2008 | 38 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 3 | 2017 | 649 | 0.080 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2007 | 21 | 0.080 |
Why?
|
| Nitrosourea Compounds | 1 | 2007 | 1 | 0.080 |
Why?
|
| Stathmin | 1 | 2007 | 2 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2007 | 8 | 0.080 |
Why?
|
| Oligodendroglioma | 1 | 2007 | 5 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2007 | 43 | 0.080 |
Why?
|
| T-Lymphocytes | 1 | 2010 | 341 | 0.080 |
Why?
|
| Uterus | 1 | 2007 | 54 | 0.080 |
Why?
|
| Male | 7 | 2021 | 18870 | 0.080 |
Why?
|
| Moloney murine leukemia virus | 1 | 2006 | 7 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2012 | 386 | 0.070 |
Why?
|
| Glucose | 1 | 2008 | 217 | 0.070 |
Why?
|
| Middle Aged | 5 | 2020 | 9642 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2007 | 184 | 0.070 |
Why?
|
| Mice, Inbred NOD | 2 | 2017 | 43 | 0.070 |
Why?
|
| Macrophage Inflammatory Proteins | 2 | 2003 | 14 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 1 | 2007 | 162 | 0.070 |
Why?
|
| Epidermal Growth Factor | 1 | 2006 | 63 | 0.070 |
Why?
|
| RNA, Messenger | 5 | 2016 | 1152 | 0.070 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2006 | 41 | 0.070 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2006 | 108 | 0.070 |
Why?
|
| Brain Ischemia | 1 | 2008 | 179 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2008 | 306 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2007 | 209 | 0.070 |
Why?
|
| Growth Inhibitors | 1 | 2004 | 23 | 0.070 |
Why?
|
| Genes, myc | 1 | 2004 | 28 | 0.070 |
Why?
|
| Alleles | 2 | 2016 | 284 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 1300 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2005 | 100 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 135 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2007 | 562 | 0.060 |
Why?
|
| Computer Simulation | 2 | 2017 | 347 | 0.060 |
Why?
|
| Tumor Burden | 2 | 2015 | 79 | 0.060 |
Why?
|
| Chemokine CCL2 | 1 | 2004 | 82 | 0.060 |
Why?
|
| Adult | 4 | 2020 | 11034 | 0.060 |
Why?
|
| Endothelial Growth Factors | 1 | 2002 | 4 | 0.060 |
Why?
|
| Lymphokines | 1 | 2002 | 11 | 0.060 |
Why?
|
| Cell Growth Processes | 2 | 2017 | 41 | 0.050 |
Why?
|
| Spheroids, Cellular | 2 | 2014 | 28 | 0.050 |
Why?
|
| Tryptophan | 1 | 2003 | 62 | 0.050 |
Why?
|
| Phosphorylation | 3 | 2011 | 878 | 0.050 |
Why?
|
| Genome, Human | 2 | 2016 | 112 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 901 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2023 | 325 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 298 | 0.050 |
Why?
|
| Fungi | 1 | 2002 | 86 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2005 | 486 | 0.050 |
Why?
|
| Asbestos, Crocidolite | 1 | 2020 | 8 | 0.050 |
Why?
|
| Genomic Instability | 1 | 2020 | 34 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2004 | 968 | 0.050 |
Why?
|
| RNA, Small Interfering | 3 | 2008 | 391 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2005 | 653 | 0.050 |
Why?
|
| Occupational Exposure | 1 | 2020 | 67 | 0.050 |
Why?
|
| RNA Interference | 2 | 2015 | 225 | 0.050 |
Why?
|
| Transplantation, Heterologous | 2 | 2013 | 87 | 0.040 |
Why?
|
| Family | 1 | 2020 | 162 | 0.040 |
Why?
|
| Cluster Analysis | 2 | 2013 | 188 | 0.040 |
Why?
|
| Neurons | 1 | 2006 | 1130 | 0.040 |
Why?
|
| Brain | 1 | 2006 | 1268 | 0.040 |
Why?
|
| Quality of Life | 1 | 2022 | 459 | 0.040 |
Why?
|
| Protein Stability | 1 | 2017 | 40 | 0.040 |
Why?
|
| Protein Phosphatase 2 | 1 | 2017 | 22 | 0.040 |
Why?
|
| Transcription, Genetic | 3 | 2006 | 550 | 0.040 |
Why?
|
| Epithelium | 1 | 2017 | 74 | 0.040 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 27 | 0.040 |
Why?
|
| Germ Cells | 1 | 2017 | 70 | 0.040 |
Why?
|
| Small Molecule Libraries | 1 | 2017 | 43 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2017 | 95 | 0.040 |
Why?
|
| Multigene Family | 1 | 2016 | 105 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 269 | 0.040 |
Why?
|
| Caspases | 2 | 2008 | 132 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2011 | 157 | 0.040 |
Why?
|
| Nevada | 1 | 2016 | 6 | 0.040 |
Why?
|
| Pleural Effusion | 1 | 2016 | 8 | 0.040 |
Why?
|
| Genealogy and Heraldry | 1 | 2015 | 3 | 0.040 |
Why?
|
| Skin | 1 | 2017 | 173 | 0.040 |
Why?
|
| Germany | 1 | 2015 | 21 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2017 | 350 | 0.030 |
Why?
|
| Pedigree | 1 | 2015 | 64 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2016 | 143 | 0.030 |
Why?
|
| Acetylation | 1 | 2016 | 94 | 0.030 |
Why?
|
| Osteopontin | 1 | 2016 | 35 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2017 | 252 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2016 | 68 | 0.030 |
Why?
|
| Young Adult | 2 | 2016 | 4012 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2017 | 467 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2007 | 423 | 0.030 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2015 | 6 | 0.030 |
Why?
|
| New York | 1 | 2015 | 69 | 0.030 |
Why?
|
| United States | 2 | 2015 | 3894 | 0.030 |
Why?
|
| DNA Damage | 1 | 2017 | 341 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 170 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2015 | 149 | 0.030 |
Why?
|
| Camptothecin | 1 | 2014 | 20 | 0.030 |
Why?
|
| Diffusion | 1 | 2013 | 49 | 0.030 |
Why?
|
| Receptors, Androgen | 1 | 2014 | 122 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 114 | 0.030 |
Why?
|
| Quinolines | 1 | 2014 | 60 | 0.030 |
Why?
|
| Cell Movement | 1 | 2017 | 545 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2014 | 171 | 0.030 |
Why?
|
| Deferoxamine | 2 | 2004 | 19 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 605 | 0.030 |
Why?
|
| Chemokine CCL3 | 2 | 2003 | 13 | 0.030 |
Why?
|
| Chemokine CCL4 | 2 | 2003 | 18 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2014 | 153 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2011 | 60 | 0.030 |
Why?
|
| Quinazolines | 1 | 2011 | 31 | 0.030 |
Why?
|
| Exons | 1 | 2011 | 80 | 0.030 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2011 | 8 | 0.030 |
Why?
|
| Cell Fusion | 1 | 2011 | 17 | 0.030 |
Why?
|
| Muscular Diseases | 1 | 2011 | 20 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 117 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2011 | 156 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 984 | 0.020 |
Why?
|
| Brain Edema | 1 | 2011 | 62 | 0.020 |
Why?
|
| Vision Disorders | 1 | 2011 | 59 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2011 | 122 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2011 | 282 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2013 | 1349 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 638 | 0.020 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2008 | 10 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2008 | 105 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2014 | 1961 | 0.020 |
Why?
|
| COS Cells | 1 | 2007 | 62 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2008 | 89 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2008 | 70 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 217 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2007 | 186 | 0.020 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2008 | 76 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2007 | 49 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2007 | 25 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 200 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2007 | 79 | 0.020 |
Why?
|
| Cell Division | 1 | 2008 | 296 | 0.020 |
Why?
|
| Terminal Repeat Sequences | 1 | 2006 | 8 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2007 | 159 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 445 | 0.020 |
Why?
|
| Hela Cells | 1 | 2007 | 344 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 269 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2006 | 18 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2006 | 12 | 0.020 |
Why?
|
| Serum | 1 | 2006 | 13 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2006 | 154 | 0.020 |
Why?
|
| Fibroblast Growth Factors | 1 | 2006 | 34 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2008 | 834 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2007 | 608 | 0.020 |
Why?
|
| Receptor, Notch1 | 1 | 2005 | 16 | 0.020 |
Why?
|
| Survival Rate | 1 | 2006 | 310 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2004 | 22 | 0.020 |
Why?
|
| Base Sequence | 1 | 2007 | 932 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2005 | 114 | 0.020 |
Why?
|
| Tetrazolium Salts | 1 | 2004 | 36 | 0.020 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2004 | 24 | 0.020 |
Why?
|
| G2 Phase | 1 | 2004 | 25 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2004 | 45 | 0.020 |
Why?
|
| G1 Phase | 1 | 2004 | 32 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2004 | 126 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2005 | 72 | 0.020 |
Why?
|
| Thiazoles | 1 | 2004 | 71 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 89 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2006 | 484 | 0.020 |
Why?
|
| RNA Stability | 1 | 2004 | 24 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 1490 | 0.020 |
Why?
|
| Ligands | 1 | 2005 | 317 | 0.020 |
Why?
|
| Genotype | 1 | 2006 | 641 | 0.010 |
Why?
|
| Phenotype | 1 | 2006 | 650 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 2002 | 4 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2002 | 37 | 0.010 |
Why?
|
| Half-Life | 1 | 2002 | 52 | 0.010 |
Why?
|
| Macrophages, Peritoneal | 1 | 2002 | 22 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2002 | 87 | 0.010 |
Why?
|
| Models, Biological | 1 | 2006 | 642 | 0.010 |
Why?
|
| Oxygen | 1 | 2004 | 193 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 396 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2002 | 69 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2002 | 5 | 0.010 |
Why?
|
| Aging | 1 | 2007 | 639 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2004 | 200 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 600 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2002 | 69 | 0.010 |
Why?
|
| Iron Chelating Agents | 1 | 2002 | 21 | 0.010 |
Why?
|
| Ferrous Compounds | 1 | 2002 | 20 | 0.010 |
Why?
|
| Mycoses | 1 | 2002 | 29 | 0.010 |
Why?
|
| Chemokines | 1 | 2003 | 89 | 0.010 |
Why?
|
| Protein Engineering | 1 | 2002 | 40 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 1124 | 0.010 |
Why?
|
| Pregnancy | 1 | 2007 | 1503 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 103 | 0.010 |
Why?
|
| DNA | 1 | 2004 | 549 | 0.010 |
Why?
|
| Cryptococcus neoformans | 1 | 2002 | 55 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 485 | 0.010 |
Why?
|
| Microglia | 1 | 2002 | 152 | 0.010 |
Why?
|
| Antifungal Agents | 1 | 2002 | 147 | 0.010 |
Why?
|
| Candida albicans | 1 | 2002 | 163 | 0.010 |
Why?
|
| Gene Expression | 1 | 2002 | 639 | 0.010 |
Why?
|